German Stroke Registry - Endovascular Treatment

The German Stroke Registry (GSR) Endovascular Treatment is an academic, independent, prospective, multicentre, observational registry study. Consecutive patients treated with endovascular stroke treatment will be enrolled in German stroke centers. Patients receive regular care and data will be collected as part of clinical routine. Baseline clinical and procedural information as well clinical follow-up information during in-hospital stay, and up to 90 days of stroke onset are collected. Data collected include demographics, National Institute of Health Stroke Scale (NIHSS) on admission, pre-treatment ASPECTS, information on timing and success of interventional treatment, procedural complications, intracranial hemorrhage, and functional outcome.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Acute Ischemic Stroke Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Ischemic Stroke Nervous System Diseases Stroke Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Medical Center Hamburg-Eppendorf (UKE)

Hamburg, Free and Hanseatic City of Hamburg, 20251, Germany

Location status: Recruiting

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Clinical diagnosis of acute ischemic stroke
Eligible for intravenous thrombolysis (IVT) and IVT initiated within 4.5 hours after stroke onset
Confirmed diagnosis of persistent occlusion of terminal carotid artery, middle cerebral artery (M1 or M2), or basilar artery consistent with symptoms
Age >18 years
Ethic approval in process

Exclusion criteria

none

Treatment and study plan

telephone call d90

Other

telephone call on day 90 to assess the primary outcome (mRs d90)

Primary outcomes

modified Ranking Scale (mRS) on day 90

Time frame: 90 days

The scale is a commonly used measurement for the degree of disability or dependence in the daily activities of people who have suffered a stroke;

scale range 0-6; with 0 - No symptoms. 1 - No significant disability. Able to carry out all usual activities, despite some symptoms. 2 - Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. 3 - Moderate disability. Requires some help, but able to walk unassisted. 4 - Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. 5 - Severe disability. Requires constant nursing care and attention, bedridden, incontinent. 6 - Dead. publication: van Swieten J, Koudstaal P, Visser M, Schouten H, et al. (1988). "Interobserver agreement for the assessment of handicap in stroke patients". Stroke. 19 (5): 604-607. doi:10.1161/01.str.19.5.604. PMID 3363593.

Interested in participating?

Recruiting

Interested in participating?

Request Info

Sponsors and collaborators

Lead sponsor

Universitätsklinikum Hamburg-Eppendorf

Other

Collaborators

Allgemeines Krankenhaus Celle
Asklepios Klinik Altona
Asklepios Klinik Wandsbek
Bezirkskrankenhaus Günzburg
Charite University, Berlin, Germany
Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum
Elbe Kliniken
Goethe University
KRH Klinikum Nordstadt
Klinikum Altenburger Land
Klinikum Bremen-Mitte, gGmbH
Klinikum Dortmund
Klinikum Köln-Merheim
Klinikum Lüneburg
Klinikum Osnabrück
Klinikum Stadt Hanau
Krankenhaus Buchholz
Ludwig-Maximilians - University of Munich
Mühlenkreiskliniken Minden
RWTH Aachen University
Sana Kliniken Lübeck
Sana Klinikum Offenbach
Städtische Klinikum Braunschweig
Technical University of Munich
University Hospital Muenster
University Hospital Tuebingen
University Hospital of Cologne
University Hospital, Bonn
University Medical Center Mainz
University Medical Center Rostock
University of Giessen and Marburg
University of Göttingen
Wuerzburg University Hospital
radprax MVZ Nordrhein

Registry information

Acronym: GSR-ET

Important dates

Study start: 2015
Primary completion: 2027
Study completion: 2027
First posted: Nov 29, 2017
Registry last updated: Dec 11, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting